Vaccines against Herpes zoster: Effectiveness, safety, and cost/benefit ratio
A vaccination against herpes zoster and its complication is available in France since June 2015. Its exact benefit for public health is still controversial and its level of protection is not optimal. All those reasons seem to suggest a low acceptation rate from general practitioners. To evaluate the...
Saved in:
Published in | La Presse médicale (1983) Vol. 45; no. 2; p. 162 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | French |
Published |
France
01.02.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!